Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
Background. To compare a titratable insulin infusion order set (vs. nontitratable) and early administration of long-acting insulin in adult patients with diabetic ketoacidosis (DKA). Methods. Single health system, retrospective study of adult patients admitted to the intensive care unit (ICU) for DK...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Critical Care Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/1601553 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561323270995968 |
|---|---|
| author | Justin Kinney Oshin Baroi Mania Gharibian |
| author_facet | Justin Kinney Oshin Baroi Mania Gharibian |
| author_sort | Justin Kinney |
| collection | DOAJ |
| description | Background. To compare a titratable insulin infusion order set (vs. nontitratable) and early administration of long-acting insulin in adult patients with diabetic ketoacidosis (DKA). Methods. Single health system, retrospective study of adult patients admitted to the intensive care unit (ICU) for DKA. The primary outcomes were insulin infusion duration and ICU/hospital length of stays (LoS). Secondary outcomes included ICU/hospital survival, hypoglycemia, and hypokalemia. Results. 151 patients were included in the titratable versus nontitratable insulin infusion comparison. Patients treated with the titratable insulin had shorter hospitalization (6.4 vs. 10.4 days, p=0.03) and reduced the number hypoglycemic events by over half (20.6% vs. 46.0%, p<0.01). 110 patients were identified to compare overlapping a long-acting insulin for more than 4 h with the insulin infusion versus the standard 1-2 h overlap. Patients who received the insulin early spent over 18 h longer on the infusion (p<0.01). Conclusions. A titratable insulin infusion added to the institutional DKA order set was associated with fewer days in the hospital and a significant reduction in hypoglycemic events. Furthermore, overlapping the long-acting insulin earlier with the insulin infusion early showed no benefit and could potentially be worse than the standard overlap. |
| format | Article |
| id | doaj-art-dc64bb79907c48cf96dceb54306433ef |
| institution | Kabale University |
| issn | 2090-1313 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Critical Care Research and Practice |
| spelling | doaj-art-dc64bb79907c48cf96dceb54306433ef2025-02-03T01:25:21ZengWileyCritical Care Research and Practice2090-13132021-01-01202110.1155/2021/1601553Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin EarlyJustin Kinney0Oshin Baroi1Mania Gharibian2Department of Pharmacy PracticeDepartment of Pharmacy PracticeDepartment of Pharmacy PracticeBackground. To compare a titratable insulin infusion order set (vs. nontitratable) and early administration of long-acting insulin in adult patients with diabetic ketoacidosis (DKA). Methods. Single health system, retrospective study of adult patients admitted to the intensive care unit (ICU) for DKA. The primary outcomes were insulin infusion duration and ICU/hospital length of stays (LoS). Secondary outcomes included ICU/hospital survival, hypoglycemia, and hypokalemia. Results. 151 patients were included in the titratable versus nontitratable insulin infusion comparison. Patients treated with the titratable insulin had shorter hospitalization (6.4 vs. 10.4 days, p=0.03) and reduced the number hypoglycemic events by over half (20.6% vs. 46.0%, p<0.01). 110 patients were identified to compare overlapping a long-acting insulin for more than 4 h with the insulin infusion versus the standard 1-2 h overlap. Patients who received the insulin early spent over 18 h longer on the infusion (p<0.01). Conclusions. A titratable insulin infusion added to the institutional DKA order set was associated with fewer days in the hospital and a significant reduction in hypoglycemic events. Furthermore, overlapping the long-acting insulin earlier with the insulin infusion early showed no benefit and could potentially be worse than the standard overlap.http://dx.doi.org/10.1155/2021/1601553 |
| spellingShingle | Justin Kinney Oshin Baroi Mania Gharibian Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early Critical Care Research and Practice |
| title | Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early |
| title_full | Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early |
| title_fullStr | Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early |
| title_full_unstemmed | Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early |
| title_short | Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early |
| title_sort | diabetic ketoacidosis updates titratable insulin infusions and long acting insulin early |
| url | http://dx.doi.org/10.1155/2021/1601553 |
| work_keys_str_mv | AT justinkinney diabeticketoacidosisupdatestitratableinsulininfusionsandlongactinginsulinearly AT oshinbaroi diabeticketoacidosisupdatestitratableinsulininfusionsandlongactinginsulinearly AT maniagharibian diabeticketoacidosisupdatestitratableinsulininfusionsandlongactinginsulinearly |